Oct. 17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin lymphoma by adding the immunotherapy nivolumab to a current treatment regimen.

Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...

The drug received accelerated approval in October 2017 as monotherapy for adults with MCL who have received at least one ...

Dilan Patel, a women's health coach, has shared his story online of unexpectedly being diagnosed with cancer at 25-years-old ...

Amanda Christine Riley defrauded people with a fake cancer scheme — now, her elaborate hoax is the subject of a new ...

Dilan Patel, a women's health coach said he was living his life as any other young adult when he started experiencing night ...

Should I get breast implants? Should they be saline or silicone? Which style? How much monitoring is needed after surgery?

Dilan Patel, a women's health coach, has taken to Instagram to share his journey after unexpectedly being diagnosed with ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...

Spasmodic dysphonia is a rare neurological disorder that causes involuntary spasms in the vocal cords, making speech strained ...

WHEN doctors dismissed 13-year-old Bebe’s tiredness as anaemia, her mum had a gut feeling there must be a more serious ...

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...